NEW YORK (PRWEB) April 24, 2019
AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as Vice President of Customer Success. In this new role, Dr. Schultz will be responsible for the clinical, operational, reporting, and account management activities of AllazoHealth’s clients, and will ensure operational excellence is delivered during all phases of the client relationship.
“AllazoHealth is widely recognized as a leading Artificial Intelligence and Machine Learning solution in the healthcare industry as it identifies, predicts, prioritizes, and selects proper interventions to ensure more successful patient outcomes,” said Dr. Schultz. “I am eager to help accelerate innovation in the healthcare industry, and AllazoHealth’s AI is a perfect fit.”
Dr. Schultz comes to AllazoHealth with over 25 years of experience in the managed care industry. Prior to joining Allazo, Dr. Schultz was the owner of a successful boutique consulting firm, RxHorizons, where she provided critical expertise to address a broad array of strategic pharmacy management and clinical initiatives in various organizations. This experience, coupled with prior roles such as Staff VP of Clinical Pharmacy at Anthem, makes her uniquely qualified to lead the Customer Success function at AllazoHealth.
“In the first quarter of 2019, AllazoHealth has already realized a 200% increase in growth. As demand continues to rise for Allazo’s Artificial Intelligence solution, we remain focused on delivering strong adherence and patient engagement outcomes for our clients,” said Chief Operating Officer, Bill Grambley. “Linda’s addition to the team, with her extensive experience in strategic management and customer relations in the managed care space, strengthens our commitment to our customers’ success.”
“I am thrilled to be part of the AllazoHealth team as we accelerate growth, build the team, and bring new innovations to the healthcare industry,” Dr. Schultz said.
Dr. Schultz joins the AllazoHealth leadership team based in New York effective immediately.
AllazoHealth is an artificial intelligence / machine learning company that focuses on driving the behavioral change of patients through personalized and proactive intervention. Our mission is to be the leader in precision engagement & predictive analytics, revolutionizing the way our enterprise healthcare clients engage and improve the health of their patient population. For more information about AllazoHealth, please visit https://allazohealth.com or email